Showing results (151-160 of 516) with videos related to

Sort By:
Pageof 52
BMC Medical Research Methodology|March 18, 2010
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokersJohn H Warner, Qiwei Liang, Mohamadi Sarkar, et al.
Regulatory Toxicology and Pharmacology : RTP|October 13, 2007
The effect of cigarette burn time on exposure to nicotine and carbon monoxide in adult smokersQiwei Liang, Hans J Roethig, Peter J Lipowicz, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2017
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016Helio S Sader, Mariana Castanheira, Dee Shortridge, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015Mariana Castanheira, Leonard R Duncan, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2026
In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United StatesJoshua M Maher, Rodrigo E Mendes, Mark Jones, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 13, 2005
Acute intoxication due to ingestion of vegetables contaminated with aldicarbCarlos A C Mendes, Gloria E Mendes, José Paulo Cipullo, et al.
Open Forum Infectious Diseases|March 2, 2023
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical CentersHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Open Forum Infectious Diseases|September 4, 2024
High Rates of Nonsusceptibility to Common Oral Antibiotics in Streptococcus pneumoniae Clinical Isolates From the United States (2019-2021)Lalitagauri M Deshpande, Michael D Huband, Sarah Charbon, et al.
Jac-Antimicrobial Resistance|August 25, 2021
Characterization of Enterobacter cloacae and Citrobacter freundii species complex isolates with decreased susceptibility to cephalosporins from United States hospitals and activity of ceftazidime/avibactam and comparator agentsHelio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 2020
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanismsRodrigo E Mendes, Michael D Huband, Jennifer M Streit, et al.
Pageof 52